{
    "title": "US FDA approves French drugmaker Ipsen's rare bone disorder drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12414511/US-FDA-approves-Ipsens-rare-bone-disorder-drug.html",
    "date": "2023-08-16",
    "keywords": [
        "drug",
        "bone",
        "disorder",
        "disease",
        "approval",
        "bhanvi",
        "satija",
        "roy",
        "growth",
        "company",
        "tissue",
        "food",
        "administration",
        "fda",
        "wednesday",
        "drugmaker",
        "treatment",
        "condition",
        "sohonos",
        "loss",
        "mobility",
        "life",
        "expectancy",
        "regulator",
        "use",
        "list",
        "price",
        "day",
        "dose",
        "weight",
        "state",
        "latestage",
        "study",
        "reduction",
        "volume",
        "formation",
        "care",
        "regeneron",
        "garetosmab",
        "health",
        "start",
        "flareup",
        "pain",
        "movement",
        "stiffness",
        "fop",
        "government",
        "ipsen",
        "blueprint",
        "corp",
        "blu782",
        "portfolio",
        "string",
        "warning",
        "toxicity",
        "premature",
        "epiphyseal",
        "closure",
        "reporting",
        "sriparna",
        "pratik",
        "jain",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}